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ABSTRACT: Polymersomes are robust, versatile nano-
structures that can be tailored by varying the chemical
structure of copolymeric building blocks, giving control
over their size, shape, surface chemistry, and membrane
permeability. In particular, the generation of nonspherical
nanostructures has attracted much attention recently, as it
has been demonstrated that shape aﬀects function in a
biomedical context. Until now, nonspherical polymer-
somes have only been constructed from nondegradable
building blocks, hampering a detailed investigation of
shape eﬀects in nanomedicine for this category of
nanostructures. Herein, we demonstrate the spontaneous
elongation of spherical polymersomes comprising the
biodegradable copolymer poly(ethylene glycol)-b-poly-
(D,L-lactide) into well-deﬁned nanotubes. The size of
these tubes is osmotically controlled using dialysis, which
makes them very easy to prepare. To conﬁrm their utility
for biomedical applications, we have demonstrated that,
alongside drug loading, functional proteins can be tethered
to the surface utilizing bio-orthogonal “click” chemistry. In
this way the present ﬁndings establish a novel platform for
the creation of biocompatible, high-aspect ratio nano-
particles for biomedical research.
Polymersomes, nanoscopic polymer vesicles self-assembledfrom synthetic block copolymers, have shown great promise
in biomedical applications from drug delivery to artiﬁcial
organelles.1 Polymersomes display enhanced stability and
membrane integrity under a wide range of conditions when
compared to liposomes, frequently used in nanomedical systems,
due to their thicker membranes.2 Polymersome morphology can
be controlled by copolymer composition and subsequently re-
engineered in response to chemical or physical stimuli such as pH,
osmotic pressure, temperature, or magnetic ﬁelds.3 The
importance of gaining control over the size and shape of
nanoparticles is essential to directing their function in vivo.4
While spherical polymersomes have shown to be successful
candidates for some applications in a biological context,5 the
ability to transform their morphology can lead to new biomedical
opportunities such as targeted drug delivery.4f
For example, it has been shown that high-aspect ratio structures
lead to enhanced speciﬁc accumulation and reduced nonspeciﬁc
adhesion to cells.6 Elongated nanoparticles interact with cells via
distinct mechanisms, leading to enhanced uptake, in a similar
fashion to the uptake of rod-like bacteria by nonphagocytotic
cells.7 Moreover, the unique ability of tubular morphologies, in
contrast to spheres, to interact with the immune system through
multivalency is an exciting prospect for the development of
artiﬁcial antigen-presenting cells.4g However, up to this point the
bulk of research toward engineering elongated polymeric vesicles
has focused on nonbiocompatible polymers. For example, tubular
nanostructures have been reported, with shape transformation
accomplished by using chemical stimuli such as the covalent
introduction of a redox cleavable cross-linker8 or by swelling the
membranewith lipids or cholesterol.9However, the utility of such
methodologies is limited by their nonbiodegradable components
or lack of structural control. It is therefore of critical importance to
develop new methodologies for the generation of well-deﬁned,
elongated polymersomes utilizing biodegradable polymers.
Biodegradable copolymers have shown excellent promise in the
development of biocompatible nanomaterials for medical
applications.4f,10 Biodegradable nanotubes can therefore be
directly implemented in nanomedical research due to their
inherent biocompatibility.11
Here,wepresent amethodology for the formationof functional,
polymeric nanotubes from biodegradable polymersomes com-
prisingpoly(ethylene glycol)-b-poly(D,L-lactide) (PEG-PDLLA).
Poly(lactides) have established utility in biomedical engineering
due to their biocompatibility and degradation behavior, which has
been shown to vary between days or weeks, depending on the
conditions employed.12 Furthermore, the formation of polymer-
somes from PEG-PDLLA block copolymers has previously been
reported.12aHerein,wedemonstrate that spherical polymersomes
comprising PEG-PDLLA block copolymers can be transformed
into well-deﬁned nanotubes by exposure to hypertonic con-
ditions, and thereby osmotic pressure, at low temperature. In this
way, nanotubes of diﬀerent lengths are controllably obtained by
varying the electrolyte concentration. Moreover, such nanotubes
can readily be functionalized through incorporation of hydro-
phobic drugs or via surface modiﬁcation with proteins utilizing
bio-orthogonal “click” chemistry.
Previously we reported the osmotically induced shape
transformation of poly(ethylene glycol)-b-poly(styrene) (PEG-
PS) polymersomes into bowl-shaped stomatocytes through
deﬂation of the inner volume and membrane indentation.13
This shapewasmaintainedbecausePS in themembranehas ahigh
glass transition temperature, which provides the necessary
membrane rigidity at room temperature to prevent structural
relaxation toward a spherical morphology. In order to understand
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in more detail the nature of the shape transformation that occurs
when spherical polymersomes are exposed to hypertonic
conditions, it is necessary to consider the bending energy (Eb)
that can be described by eq 1:14,15
∮= −E k C C dA2 (2 )b 0 2 (1)
Eq 1 allows us to describe the energetic state of a polymersomal
membrane as a function of 3 parameters: the bending rigidity (k),
the mean surface curvature (C), and the spontaneous curvature
(C0). The bending rigidity (k) is dictated by the chemical
properties of the membrane (polymer composition and length)
alongside environmental factors (temperature and solvent
composition). The mean surface curvature (C) describes the
degree of curvature at diﬀerent positions on the membrane and is
contingent upon the shape. In contrast to C, the spontaneous
curvature (C0) is not a consequence of the shape; rather, it arises
from asymmetry in copolymer conformation between the inner
and outer surfaces and is therefore sensitive to the membrane
microenvironment. From eq 1we understand that the eﬀect ofC0
is to either reduce or increase Eb for a given morphology and, as
such, can be used to gain control over the shape transformation
process.14 Under the inﬂuence of osmotic pressure, which can be
orders of magnitude greater than Eb, as a spherical polymersome
undergoes reduction involume there are2energeticpathways that
can be taken. Such deﬂation can proceed via prolates (toward
tubes)or oblates (towarddiscs and stomatocytes) as a result of the
minimization ofEb, with the determining factor beingC0.Without
signiﬁcant contribution from the eﬀect ofC0, the prolate pathway
has a lower energetic proﬁle, however, a positive or negative
contribution of C0 would favor either prolates or oblates,
respectively.15 With this in mind, it is clear that ﬁnding a suitable
biodegradable replacement for poly(styrene), which is suﬃciently
rigidwhile tending toward prolates and tubes rather thandiscoidal
structures, is a challenging task.
Shape transformations of self-assembled structures using most
common poly(esters) and poly(carbonates), even with careful
tuning of conditions, are extremely challenging due to their
amorphous (lowTg) or crystalline (highTm) character. However,
atactic polylactide, synthesized from a mixture of lactide isomers,
possesses aTg above 20 °C(asopposed to the isotactic form that is
highly crystalline) and is therefore an excellent candidate for the
formation of biodegradable polymersomes and their shape
transformed counterparts.16 PEG-PDLLA copolymers were
synthesized by ring-opening polymerization (ROP) with the
organic base 1,8-diazabicycloundec-7-ene (DBU) as a catalyst,
according to previous literature (Figure 1a).17 The reaction
progress and the composition of the ﬁnal product were calculated
from the NMR spectra (Figures S1 and S2) with the resulting
copolymers having PDI values of <1.1 (Figure S3). Two
copolymers were synthesized, PEG22-b-PDLLA45 (Mw ≈ 7.5
kDa) and PEG44-b-PDLLA90 (Mw ≈ 14.9 kDa), both comprising
∼13 wt % PEG. Diﬀerential scanning calorimetry (DSC) data
conﬁrmed that the Tg values for PEG22-PDLLA45 and PEG44-
PDLLA90 were ∼26 and 30 °C, respectively (Figure S4).
Assembly tests using PEG-PDLLA were conducted using an
established method for polymersome formation via solvent
switch, whereby a solution of block copolymer in organic solvent
(4:1, THF:dioxane)was diluted bywater (up to 50% v/v at 1mL/
h, Figure 1b).18 Interestingly, the longer copolymer PEG44-
PDLLA90 yielded micelles (spherical and rods, Figure S5a),
whereas PEG22-PDLLA45 yielded polymersomes with a hydro-
dynamic radius (Rh) ≈ 165 nm and a 15 nm thick membrane
(Figures 2a and S5b−d). In order to transform the spherical
polymersomes into nanotubes, the plasticized dispersion was
dialyzed against aqueous solutionswith varying salt concentration
(5, 10, and 50mM) at 4 °C so that the glassiness of themembrane
was maintained after the main part of organic solvent was
removed. It was observed that after overnight dialysis against 5
mM NaCl the polymersomes had partially transformed into
prolate structures, and a mixture of morphologies was observed
(Figures 2b and S6a). By comparison, dialysis against higher
[NaCl] (10 and50mM)resulted in thepredominant formationof
elongated (prolate) nanotubes of increasing length (Figures 2c,d
and S6b,c). Interestingly, polymersome dialysis against 100 mM
NaCl resulted in the formation of elongated ribbons, identiﬁed as
collapsed nanotubes (Figure S6d). Conversely, when dialyzing
the spherical polymersomesat25°C,noshape transformationwas
observed while at 30 °C collapsed structures were obtained
(Figures S6e-f), highlighting the importance of polymer rigidity
for establishing and maintaining the shape transformation.
Figure 1. Schematic outlining (a) the organobase-catalyzed synthesis of
PEG-PDLLA and (b) the osmotically induced shape transformation of
spherical polymersomes into nanotubes.
Figure 2. Cryo-TEM images following the shape transformation of
PEG22-PDLLA45 from (a) spherical polymersomes into elongated
nanotubes under the inﬂuence of osmotic pressure by dialysis, as a
function of [NaCl]; (b) 5, (c) 10, and (d) 50mM.All scale bars = 500 nm.
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Nanotubes formed using dialysis against 10 mMNaCl were on
average shorter, with average dimensions (length×width) of 110
× 800 nm, whereas dialysis against 50 mM NaCl yielded longer
tubes of 90 × 1040 nm (Figures 2c,d, S6b,c, and S7). Crucially,
these dimensions correspond to average surface areas of∼3× 106
nm2, similar to that of the original polymersomes, however, the
internal volume signiﬁcantly decreased by 39 and 51% for the
samples dialyzed against 10 and 50mMNaCl, respectively (Table
S1). This highlights that increased osmotic pressure results in
nanotube elongation due to the geometrical constraint of surface
area during osmosis and concomitant reduction of internal
volume.Asymmetricﬂowﬁeld-ﬂowfractionation(AF4, settings in
Table S2), in combinationwith static anddynamic light scattering,
were used in order to gain a quantitative understanding of the
shape transformation fromvesicles to tubes.Comparing the radius
of gyration (Rg) to the hydrodynamic radius (Rh) gives
information on particle shape where values of Rg/Rh for spheres
are ≤1 and for prolates (rod-like shapes) are >1.36.19 Elution
proﬁles, with corresponding values for Rg, clearly showed that the
spherical PEG-PDLLA polymersomes have a uniform ratio value
near to1(hollowspheres),whereas thenanotubeshaveanaverage
valueof 1.5with all values>1.3,whichquantitatively demonstrates
that the predominant morphology is that of tubes (Figure S8).
Light scattering and cryo-TEM were used to conﬁrm that
nanotubes, once formed, are stable under increased temperature
and salt concentration, as would be encountered under
physiological conditions, which is vital for application toward
biomedical research. Indeed, tubular morphology was sustained
after dialysis against PBS, with both theRh and scattering intensity
remaining constant duringheating to40 °C,due to lackof osmotic
pressure (Figure S9).
Under hypertonic conditions, polymersomes comprising
PEG22-PDLLA45 deﬂate into nanotubes rather than stomatoso-
mal or nested structures, which are more commonly encoun-
tered.13,20Ashas alreadybeendiscussed, the contributionofC0 is a
deciding factor for the direction of shape transformations. In our
previous work using PEG-PS polymersomes, a less permeable PS
membrane and longer PEG chains at the surface led to a negative
C0, which induced the formation of oblates, stomatocytes and
nested vesicles.13,14b In comparison, for the shape transformation
of PEG-PDLLA polymersomes, increasing the [NaCl] during
dialysis not only results in greater volume reduction but also
inﬂuences the transformation pathway. Dialyzing polymersomes
against 5 mM NaCl resulted in the formation of a population of
heterogeneous morphologies, dominated by prolates, which is
unsuitable for quantiﬁcation (Figures 2b and S6a). However,
increasing the [NaCl] to 10 and 50 mM gave a signiﬁcant
improvement in the quantity (and quality) of prolate structures,
concurrently lowering the percentage of oblate morphologies to
∼10 and 4%, respectively (Figures 2c,d and S6b). Interestingly,
dialysis under increased osmotic pressure (100 mMNaCl) led to
the formation of nanotubes that underwent total collapse due to
outﬂow of all internal solvent molecules during the shape
transformation process. These results suggest that not only does
NaCl contribute toward solution osmolarity, which drives volume
reduction and elongation, but it also contributes toward a positive
C0, promoting the formation of prolates and tubes. Although the
physical origins ofC0 are not well documented, it is evident that it
arises from a mismatch between the external and internal
membrane surfaces. Such a mismatch is accentuated by chemical
diﬀerences between external and internal environments, which is
the case in the current situation. Although it is beyond the scope of
the present work, these ﬁndings warrant further investigation into
the unique properties of PEG-PDLLA in order to develop
experimental insight into the contribution of C0 in shape
transformations.
In order to establish the functional capacity of PEG-PDLLA
nanotubes, experiments were conducted to demonstrate
biomolecular labeling (Figure 3a−c) and drug loading (Figure
3d−f). Biomolecular labeling of nanoparticles is an important
procedure by which biological activity can be introduced to the
surface through covalentmodiﬁcationwith antibodies or antigens
in order to provide site-selective speciﬁcity in cellular uptake or to
stimulate speciﬁc immune responses.21 It is therefore important to
demonstrate that the nanotubes can be modiﬁed with surface-
bound biomolecules, which retain their native function after
attachment. For this purpose, enhanced green ﬂuorescent protein
(eGFP) containing the clickable unnatural amino acid
bicyclo[6.1.0]nonyne-L-lysine (BCN-lys) was expressed and
puriﬁed (eGFPBCN, Figures 3a and S10). Azido-modiﬁed
copolymer (N3-PEG75-PDLLA45) was introduced into the
nanotubes at diﬀerent amounts (2 and 5 wt %) to demonstrate
that control over the density of biomolecular labeling can be
accomplished through simple formulation. Flow cytometry and
confocal microscopy were used to conﬁrm successful labeling of
eGFP onto the nanotube, with a positive signal indicating that the
tethered eGFP maintains its native structure (Figure 3).22 The
stability of eGFP modiﬁed N3-nanotubes was conﬁrmed by cryo-
TEM (Figure S11a). With ﬂow cytometry the N3-nanotubes
showed increases in their ﬂuorescent signal upon increasing the
Figure 3. (a) Schematic outlining the covalent modiﬁcation of azide-
modiﬁed nanotubes using eGFPBCN, (b) ﬂow cytometry data for eGFP
modiﬁcation of 5% azido nanotubes using an equimolar (ii) or a 3-fold
excess (iii) of eGFPBCN compared to unmodiﬁed tubes (i) and (c)
confocal visualization of green-ﬂuorescent nanotubes. (d) Schematic
outlining the loading of nanotubes with ﬂuorescent DOX, (e) ﬂow
cytometry data of nanotubes loaded with 2 (ii) and 5 (iii) wt % DOX
compared to unloaded tubes (i) and (f) confocal visualization of DOX-
loaded nanotubes (5 wt % preparation). All scale bars = 5 μm.
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concentration of eGFPBCN in the reaction mixtures from an
equimolar amount to a 3-fold excess (Figures 3b and S11c) as well
as by increasing the total N3-copolymer content from 2 to 5 wt %
(Figure S11d). It was furthermore investigated if hydrophobic
cargo could be loaded in the polymer membrane without
undesired eﬀects on nanotube formation, at levels comparable
to literature.23 To this end, PEG-PDLLA nanotubes were
prepared in the presence of 2 and 5 wt % of hydrophobic
doxorubicin (DOX), whichwas dissolved into the organic solvent
phase and then became incorporated into the copolymer
membrane. As was conﬁrmed by cryo-TEM, DOX did not
impede the subsequent shape transformation (FigureS11b).Flow
cytometry was used to conﬁrm nanotube ﬂuorescence, which
increasedwith greater amounts ofDOX, although it is likely that 5
wt % is above the capacity for this system as the signal did not
greatly increase in comparison with 2 wt % loading (Figure 3e).
Speciﬁc association of the drugwith the nanotubes was conﬁrmed
using confocal microscopy (Figure 3f).
In summary, we have presented the synthesis of biodegradable
PEG-PDLLA copolymers that spontaneously assemble into
spherical polymersomes. These biodegradable polymersomes
can then undergo shape transformation into nanotubes upon
dialysis under hypertonic conditions, with increasing [NaCl]
leading to both structural enrichment and elongation. Such well-
deﬁned nanoparticles, which can be easily functionalized, are of
great interest for biomedical research where nanoscopic control
over size and shape is highly valuable.
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